Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
3.1.2 Other PEDs This group included other substances prohibited by WADA, such as non-approved substances (BPC-157) from Section S0, other anabolic agents (clenbuterol and SARMs) from Subsection S0, S1.2, peptide hormones and their releasing factors (AOD-9604, hGH 176-191, CJC-1295, ibutamoren, ipamorelin, and growth hormone-releasing peptide) from S2.2, growth factors and growth factor modulators (thymosin-4 and its derivative TB-500) from S2.3, beta-2 agonists (salbutamol and indacaterol) from S3, metabolic modulators (meldonium, GW1516, SR9009, SR9011, and insulins) from Section S4.4, and thyroid hormones
Whether the delivered amount crosses the threshold for therapeutic effect in any given individual also remains unknown
The future of peptide discussions will focus on integrating them into a comprehensive health system, and within six months, there are expected to be good physician options available for everyone, making it easier for people to access peptide therapy under medical supervision 2m42s
Tissue studies BPC-157 and TB-500 are studied in tissue and blood-supply models
What Is BPC-157 and Why Does It Matter BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids, derived from a naturally occurring protective protein found in human gastric juice
